Back to School: How biopharma can reboot drug development. Access exclusive analysis here

REG1 anticoagulation system: Phase Ia data

In a Phase Ia trial in 84 patients, an IV bolus injection of RB006

Read the full 143 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE